Global Cell Therapy CDMO Services Market Growth (Status and Outlook) 2026-2032
The global Cell Therapy CDMO Services market size is predicted to grow from US$ 2278 million in 2025 to US$ 8838 million in 2032; it is expected to grow at a CAGR of 21.8% from 2026 to 2032.
Cell therapy refers to the transfer of new cells, or cells that have been modified in a laboratory to achieve particular characteristics, into the body to prevent or treat a disease. A Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services to pharmaceutical, biotechnology, and medical device companies. CDMOs offer contract services for product development, formulation, manufacturing, packaging, and distribution. Contract development and manufacturing organizations (CDMOs) play a vital role in cell therapy development by offering crucial infrastructure and expertise.This report mainly focuses on cell therapy CDMO services market.
The cell therapy CDMO market is mainly concentrated in the following regions: North America (especially the United States) is the leader in the global cell therapy CDMO market, with advanced technology, a sound regulatory system and a large number of biopharmaceutical companies. The active support of the US FDA for cell therapy has also driven the growth of the market in the region. The European market also performed strongly, mainly due to the EU's support for cell therapy research and development and the regulatory framework of the EMA (European Medicines Agency). The United Kingdom, Germany and Switzerland are the main markets in Europe. The Asia-Pacific region (especially China, Japan and South Korea) is one of the fastest growing markets. The Chinese government's policy support and financial investment in the field of cell therapy, as well as Japan's leading position in regenerative medicine, have driven the rapid development of the market in the region. The markets in Latin America and the Middle East are relatively small, but with the popularization of cell therapy technology and the improvement of medical infrastructure, the market potential in these regions is gradually being released.
Challenges and Opportunities:
Challenges: The manufacturing process of cell therapy products is complex, requires high quality control, and is expensive. In addition, the instability of the global supply chain and the shortage of raw materials may also affect the delivery of CDMO services. Opportunities: With the advancement of technology and the optimization of manufacturing processes, CDMO companies have the opportunity to further expand their market share by providing efficient and low-cost services. In addition, the rise of emerging markets and the growing demand for personalized medicine have also provided new growth points for CDMO companies.
LPI (LP Information)' newest research report, the “Cell Therapy CDMO Services Industry Forecast” looks at past sales and reviews total world Cell Therapy CDMO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Therapy CDMO Services sales for 2026 through 2032. With Cell Therapy CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy CDMO Services market by product type, application, key players and key regions and countries.
Cell therapy refers to the transfer of new cells, or cells that have been modified in a laboratory to achieve particular characteristics, into the body to prevent or treat a disease. A Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services to pharmaceutical, biotechnology, and medical device companies. CDMOs offer contract services for product development, formulation, manufacturing, packaging, and distribution. Contract development and manufacturing organizations (CDMOs) play a vital role in cell therapy development by offering crucial infrastructure and expertise.This report mainly focuses on cell therapy CDMO services market.
The cell therapy CDMO market is mainly concentrated in the following regions: North America (especially the United States) is the leader in the global cell therapy CDMO market, with advanced technology, a sound regulatory system and a large number of biopharmaceutical companies. The active support of the US FDA for cell therapy has also driven the growth of the market in the region. The European market also performed strongly, mainly due to the EU's support for cell therapy research and development and the regulatory framework of the EMA (European Medicines Agency). The United Kingdom, Germany and Switzerland are the main markets in Europe. The Asia-Pacific region (especially China, Japan and South Korea) is one of the fastest growing markets. The Chinese government's policy support and financial investment in the field of cell therapy, as well as Japan's leading position in regenerative medicine, have driven the rapid development of the market in the region. The markets in Latin America and the Middle East are relatively small, but with the popularization of cell therapy technology and the improvement of medical infrastructure, the market potential in these regions is gradually being released.
Challenges and Opportunities:
Challenges: The manufacturing process of cell therapy products is complex, requires high quality control, and is expensive. In addition, the instability of the global supply chain and the shortage of raw materials may also affect the delivery of CDMO services. Opportunities: With the advancement of technology and the optimization of manufacturing processes, CDMO companies have the opportunity to further expand their market share by providing efficient and low-cost services. In addition, the rise of emerging markets and the growing demand for personalized medicine have also provided new growth points for CDMO companies.
LPI (LP Information)' newest research report, the “Cell Therapy CDMO Services Industry Forecast” looks at past sales and reviews total world Cell Therapy CDMO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Therapy CDMO Services sales for 2026 through 2032. With Cell Therapy CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Preclinical Stage
- Clinical Commercialization Stage
Segmentation by Application:
- Pharmaceutical Company
- Research Institute
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Charles River Laboratories
- AGC Biologics
- FUJIFILM Cellular Dynamics
- Thermo Fisher Scientific
- Wuxi AppTec
- Lonza
- KBI Biopharma
- RoslinCT
- Cell and Gene Therapy Catapult
- Cell Therapies
- Minaris Regenerative Medicine
- MEDINET
- Catalent Biologics
- Oxford BioMedica
- GenScript
- Cell-Easy
- SK pharmteco
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy CDMO Services Market Size (2021-2032)
2.1.2 Cell Therapy CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell Therapy CDMO Services by Country/Region (2021, 2025 & 2032)
2.2 Cell Therapy CDMO Services Segment by Type
2.2.1 Preclinical Stage
2.2.2 Clinical Commercialization Stage
2.2.3 Cell Therapy CDMO Services Market Size by Type
2.2.3.1 Cell Therapy CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
2.3 Cell Therapy CDMO Services Segment by Application
2.3.1 Pharmaceutical Company
2.3.2 Research Institute
2.3.3 Cell Therapy CDMO Services Market Size by Application
2.3.3.1 Cell Therapy CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
3 CELL THERAPY CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Cell Therapy CDMO Services Market Size Market Share by Player
3.1.1 Global Cell Therapy CDMO Services Revenue by Player (2021-2026)
3.1.2 Global Cell Therapy CDMO Services Revenue Market Share by Player (2021-2026)
3.2 Global Cell Therapy CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO SERVICES BY REGION
4.1 Cell Therapy CDMO Services Market Size by Region (2021-2026)
4.2 Global Cell Therapy CDMO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell Therapy CDMO Services Market Size Growth (2021-2026)
4.4 APAC Cell Therapy CDMO Services Market Size Growth (2021-2026)
4.5 Europe Cell Therapy CDMO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell Therapy CDMO Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell Therapy CDMO Services Market Size by Country (2021-2026)
5.2 Americas Cell Therapy CDMO Services Market Size by Type (2021-2026)
5.3 Americas Cell Therapy CDMO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy CDMO Services Market Size by Region (2021-2026)
6.2 APAC Cell Therapy CDMO Services Market Size by Type (2021-2026)
6.3 APAC Cell Therapy CDMO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Therapy CDMO Services Market Size by Country (2021-2026)
7.2 Europe Cell Therapy CDMO Services Market Size by Type (2021-2026)
7.3 Europe Cell Therapy CDMO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy CDMO Services by Region (2021-2026)
8.2 Middle East & Africa Cell Therapy CDMO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell Therapy CDMO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL THERAPY CDMO SERVICES MARKET FORECAST
10.1 Global Cell Therapy CDMO Services Forecast by Region (2027-2032)
10.1.1 Global Cell Therapy CDMO Services Forecast by Region (2027-2032)
10.1.2 Americas Cell Therapy CDMO Services Forecast
10.1.3 APAC Cell Therapy CDMO Services Forecast
10.1.4 Europe Cell Therapy CDMO Services Forecast
10.1.5 Middle East & Africa Cell Therapy CDMO Services Forecast
10.2 Americas Cell Therapy CDMO Services Forecast by Country (2027-2032)
10.2.1 United States Market Cell Therapy CDMO Services Forecast
10.2.2 Canada Market Cell Therapy CDMO Services Forecast
10.2.3 Mexico Market Cell Therapy CDMO Services Forecast
10.2.4 Brazil Market Cell Therapy CDMO Services Forecast
10.3 APAC Cell Therapy CDMO Services Forecast by Region (2027-2032)
10.3.1 China Cell Therapy CDMO Services Market Forecast
10.3.2 Japan Market Cell Therapy CDMO Services Forecast
10.3.3 Korea Market Cell Therapy CDMO Services Forecast
10.3.4 Southeast Asia Market Cell Therapy CDMO Services Forecast
10.3.5 India Market Cell Therapy CDMO Services Forecast
10.3.6 Australia Market Cell Therapy CDMO Services Forecast
10.4 Europe Cell Therapy CDMO Services Forecast by Country (2027-2032)
10.4.1 Germany Market Cell Therapy CDMO Services Forecast
10.4.2 France Market Cell Therapy CDMO Services Forecast
10.4.3 UK Market Cell Therapy CDMO Services Forecast
10.4.4 Italy Market Cell Therapy CDMO Services Forecast
10.4.5 Russia Market Cell Therapy CDMO Services Forecast
10.5 Middle East & Africa Cell Therapy CDMO Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell Therapy CDMO Services Forecast
10.5.2 South Africa Market Cell Therapy CDMO Services Forecast
10.5.3 Israel Market Cell Therapy CDMO Services Forecast
10.5.4 Turkey Market Cell Therapy CDMO Services Forecast
10.6 Global Cell Therapy CDMO Services Forecast by Type (2027-2032)
10.7 Global Cell Therapy CDMO Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell Therapy CDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Information
11.1.2 Charles River Laboratories Cell Therapy CDMO Services Product Offered
11.1.3 Charles River Laboratories Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Charles River Laboratories Main Business Overview
11.1.5 Charles River Laboratories Latest Developments
11.2 AGC Biologics
11.2.1 AGC Biologics Company Information
11.2.2 AGC Biologics Cell Therapy CDMO Services Product Offered
11.2.3 AGC Biologics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 AGC Biologics Main Business Overview
11.2.5 AGC Biologics Latest Developments
11.3 FUJIFILM Cellular Dynamics
11.3.1 FUJIFILM Cellular Dynamics Company Information
11.3.2 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Offered
11.3.3 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 FUJIFILM Cellular Dynamics Main Business Overview
11.3.5 FUJIFILM Cellular Dynamics Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Cell Therapy CDMO Services Product Offered
11.4.3 Thermo Fisher Scientific Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Wuxi AppTec
11.5.1 Wuxi AppTec Company Information
11.5.2 Wuxi AppTec Cell Therapy CDMO Services Product Offered
11.5.3 Wuxi AppTec Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Wuxi AppTec Main Business Overview
11.5.5 Wuxi AppTec Latest Developments
11.6 Lonza
11.6.1 Lonza Company Information
11.6.2 Lonza Cell Therapy CDMO Services Product Offered
11.6.3 Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Lonza Main Business Overview
11.6.5 Lonza Latest Developments
11.7 KBI Biopharma
11.7.1 KBI Biopharma Company Information
11.7.2 KBI Biopharma Cell Therapy CDMO Services Product Offered
11.7.3 KBI Biopharma Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 KBI Biopharma Main Business Overview
11.7.5 KBI Biopharma Latest Developments
11.8 RoslinCT
11.8.1 RoslinCT Company Information
11.8.2 RoslinCT Cell Therapy CDMO Services Product Offered
11.8.3 RoslinCT Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 RoslinCT Main Business Overview
11.8.5 RoslinCT Latest Developments
11.9 Cell and Gene Therapy Catapult
11.9.1 Cell and Gene Therapy Catapult Company Information
11.9.2 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Offered
11.9.3 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cell and Gene Therapy Catapult Main Business Overview
11.9.5 Cell and Gene Therapy Catapult Latest Developments
11.10 Cell Therapies
11.10.1 Cell Therapies Company Information
11.10.2 Cell Therapies Cell Therapy CDMO Services Product Offered
11.10.3 Cell Therapies Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cell Therapies Main Business Overview
11.10.5 Cell Therapies Latest Developments
11.11 Minaris Regenerative Medicine
11.11.1 Minaris Regenerative Medicine Company Information
11.11.2 Minaris Regenerative Medicine Cell Therapy CDMO Services Product Offered
11.11.3 Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Minaris Regenerative Medicine Main Business Overview
11.11.5 Minaris Regenerative Medicine Latest Developments
11.12 MEDINET
11.12.1 MEDINET Company Information
11.12.2 MEDINET Cell Therapy CDMO Services Product Offered
11.12.3 MEDINET Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 MEDINET Main Business Overview
11.12.5 MEDINET Latest Developments
11.13 Catalent Biologics
11.13.1 Catalent Biologics Company Information
11.13.2 Catalent Biologics Cell Therapy CDMO Services Product Offered
11.13.3 Catalent Biologics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Catalent Biologics Main Business Overview
11.13.5 Catalent Biologics Latest Developments
11.14 Oxford BioMedica
11.14.1 Oxford BioMedica Company Information
11.14.2 Oxford BioMedica Cell Therapy CDMO Services Product Offered
11.14.3 Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Oxford BioMedica Main Business Overview
11.14.5 Oxford BioMedica Latest Developments
11.15 GenScript
11.15.1 GenScript Company Information
11.15.2 GenScript Cell Therapy CDMO Services Product Offered
11.15.3 GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 GenScript Main Business Overview
11.15.5 GenScript Latest Developments
11.16 Cell-Easy
11.16.1 Cell-Easy Company Information
11.16.2 Cell-Easy Cell Therapy CDMO Services Product Offered
11.16.3 Cell-Easy Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Cell-Easy Main Business Overview
11.16.5 Cell-Easy Latest Developments
11.17 SK pharmteco
11.17.1 SK pharmteco Company Information
11.17.2 SK pharmteco Cell Therapy CDMO Services Product Offered
11.17.3 SK pharmteco Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 SK pharmteco Main Business Overview
11.17.5 SK pharmteco Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Therapy CDMO Services Market Size (2021-2032)
2.1.2 Cell Therapy CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell Therapy CDMO Services by Country/Region (2021, 2025 & 2032)
2.2 Cell Therapy CDMO Services Segment by Type
2.2.1 Preclinical Stage
2.2.2 Clinical Commercialization Stage
2.2.3 Cell Therapy CDMO Services Market Size by Type
2.2.3.1 Cell Therapy CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
2.3 Cell Therapy CDMO Services Segment by Application
2.3.1 Pharmaceutical Company
2.3.2 Research Institute
2.3.3 Cell Therapy CDMO Services Market Size by Application
2.3.3.1 Cell Therapy CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
3 CELL THERAPY CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Cell Therapy CDMO Services Market Size Market Share by Player
3.1.1 Global Cell Therapy CDMO Services Revenue by Player (2021-2026)
3.1.2 Global Cell Therapy CDMO Services Revenue Market Share by Player (2021-2026)
3.2 Global Cell Therapy CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO SERVICES BY REGION
4.1 Cell Therapy CDMO Services Market Size by Region (2021-2026)
4.2 Global Cell Therapy CDMO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell Therapy CDMO Services Market Size Growth (2021-2026)
4.4 APAC Cell Therapy CDMO Services Market Size Growth (2021-2026)
4.5 Europe Cell Therapy CDMO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell Therapy CDMO Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell Therapy CDMO Services Market Size by Country (2021-2026)
5.2 Americas Cell Therapy CDMO Services Market Size by Type (2021-2026)
5.3 Americas Cell Therapy CDMO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Therapy CDMO Services Market Size by Region (2021-2026)
6.2 APAC Cell Therapy CDMO Services Market Size by Type (2021-2026)
6.3 APAC Cell Therapy CDMO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Therapy CDMO Services Market Size by Country (2021-2026)
7.2 Europe Cell Therapy CDMO Services Market Size by Type (2021-2026)
7.3 Europe Cell Therapy CDMO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Therapy CDMO Services by Region (2021-2026)
8.2 Middle East & Africa Cell Therapy CDMO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell Therapy CDMO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL THERAPY CDMO SERVICES MARKET FORECAST
10.1 Global Cell Therapy CDMO Services Forecast by Region (2027-2032)
10.1.1 Global Cell Therapy CDMO Services Forecast by Region (2027-2032)
10.1.2 Americas Cell Therapy CDMO Services Forecast
10.1.3 APAC Cell Therapy CDMO Services Forecast
10.1.4 Europe Cell Therapy CDMO Services Forecast
10.1.5 Middle East & Africa Cell Therapy CDMO Services Forecast
10.2 Americas Cell Therapy CDMO Services Forecast by Country (2027-2032)
10.2.1 United States Market Cell Therapy CDMO Services Forecast
10.2.2 Canada Market Cell Therapy CDMO Services Forecast
10.2.3 Mexico Market Cell Therapy CDMO Services Forecast
10.2.4 Brazil Market Cell Therapy CDMO Services Forecast
10.3 APAC Cell Therapy CDMO Services Forecast by Region (2027-2032)
10.3.1 China Cell Therapy CDMO Services Market Forecast
10.3.2 Japan Market Cell Therapy CDMO Services Forecast
10.3.3 Korea Market Cell Therapy CDMO Services Forecast
10.3.4 Southeast Asia Market Cell Therapy CDMO Services Forecast
10.3.5 India Market Cell Therapy CDMO Services Forecast
10.3.6 Australia Market Cell Therapy CDMO Services Forecast
10.4 Europe Cell Therapy CDMO Services Forecast by Country (2027-2032)
10.4.1 Germany Market Cell Therapy CDMO Services Forecast
10.4.2 France Market Cell Therapy CDMO Services Forecast
10.4.3 UK Market Cell Therapy CDMO Services Forecast
10.4.4 Italy Market Cell Therapy CDMO Services Forecast
10.4.5 Russia Market Cell Therapy CDMO Services Forecast
10.5 Middle East & Africa Cell Therapy CDMO Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell Therapy CDMO Services Forecast
10.5.2 South Africa Market Cell Therapy CDMO Services Forecast
10.5.3 Israel Market Cell Therapy CDMO Services Forecast
10.5.4 Turkey Market Cell Therapy CDMO Services Forecast
10.6 Global Cell Therapy CDMO Services Forecast by Type (2027-2032)
10.7 Global Cell Therapy CDMO Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell Therapy CDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Information
11.1.2 Charles River Laboratories Cell Therapy CDMO Services Product Offered
11.1.3 Charles River Laboratories Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Charles River Laboratories Main Business Overview
11.1.5 Charles River Laboratories Latest Developments
11.2 AGC Biologics
11.2.1 AGC Biologics Company Information
11.2.2 AGC Biologics Cell Therapy CDMO Services Product Offered
11.2.3 AGC Biologics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 AGC Biologics Main Business Overview
11.2.5 AGC Biologics Latest Developments
11.3 FUJIFILM Cellular Dynamics
11.3.1 FUJIFILM Cellular Dynamics Company Information
11.3.2 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Offered
11.3.3 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 FUJIFILM Cellular Dynamics Main Business Overview
11.3.5 FUJIFILM Cellular Dynamics Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Cell Therapy CDMO Services Product Offered
11.4.3 Thermo Fisher Scientific Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Wuxi AppTec
11.5.1 Wuxi AppTec Company Information
11.5.2 Wuxi AppTec Cell Therapy CDMO Services Product Offered
11.5.3 Wuxi AppTec Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Wuxi AppTec Main Business Overview
11.5.5 Wuxi AppTec Latest Developments
11.6 Lonza
11.6.1 Lonza Company Information
11.6.2 Lonza Cell Therapy CDMO Services Product Offered
11.6.3 Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Lonza Main Business Overview
11.6.5 Lonza Latest Developments
11.7 KBI Biopharma
11.7.1 KBI Biopharma Company Information
11.7.2 KBI Biopharma Cell Therapy CDMO Services Product Offered
11.7.3 KBI Biopharma Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 KBI Biopharma Main Business Overview
11.7.5 KBI Biopharma Latest Developments
11.8 RoslinCT
11.8.1 RoslinCT Company Information
11.8.2 RoslinCT Cell Therapy CDMO Services Product Offered
11.8.3 RoslinCT Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 RoslinCT Main Business Overview
11.8.5 RoslinCT Latest Developments
11.9 Cell and Gene Therapy Catapult
11.9.1 Cell and Gene Therapy Catapult Company Information
11.9.2 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Offered
11.9.3 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cell and Gene Therapy Catapult Main Business Overview
11.9.5 Cell and Gene Therapy Catapult Latest Developments
11.10 Cell Therapies
11.10.1 Cell Therapies Company Information
11.10.2 Cell Therapies Cell Therapy CDMO Services Product Offered
11.10.3 Cell Therapies Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cell Therapies Main Business Overview
11.10.5 Cell Therapies Latest Developments
11.11 Minaris Regenerative Medicine
11.11.1 Minaris Regenerative Medicine Company Information
11.11.2 Minaris Regenerative Medicine Cell Therapy CDMO Services Product Offered
11.11.3 Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Minaris Regenerative Medicine Main Business Overview
11.11.5 Minaris Regenerative Medicine Latest Developments
11.12 MEDINET
11.12.1 MEDINET Company Information
11.12.2 MEDINET Cell Therapy CDMO Services Product Offered
11.12.3 MEDINET Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 MEDINET Main Business Overview
11.12.5 MEDINET Latest Developments
11.13 Catalent Biologics
11.13.1 Catalent Biologics Company Information
11.13.2 Catalent Biologics Cell Therapy CDMO Services Product Offered
11.13.3 Catalent Biologics Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Catalent Biologics Main Business Overview
11.13.5 Catalent Biologics Latest Developments
11.14 Oxford BioMedica
11.14.1 Oxford BioMedica Company Information
11.14.2 Oxford BioMedica Cell Therapy CDMO Services Product Offered
11.14.3 Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Oxford BioMedica Main Business Overview
11.14.5 Oxford BioMedica Latest Developments
11.15 GenScript
11.15.1 GenScript Company Information
11.15.2 GenScript Cell Therapy CDMO Services Product Offered
11.15.3 GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 GenScript Main Business Overview
11.15.5 GenScript Latest Developments
11.16 Cell-Easy
11.16.1 Cell-Easy Company Information
11.16.2 Cell-Easy Cell Therapy CDMO Services Product Offered
11.16.3 Cell-Easy Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Cell-Easy Main Business Overview
11.16.5 Cell-Easy Latest Developments
11.17 SK pharmteco
11.17.1 SK pharmteco Company Information
11.17.2 SK pharmteco Cell Therapy CDMO Services Product Offered
11.17.3 SK pharmteco Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 SK pharmteco Main Business Overview
11.17.5 SK pharmteco Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell Therapy CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell Therapy CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Preclinical Stage
Table 4. Major Players of Clinical Commercialization Stage
Table 5. Cell Therapy CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Table 8. Cell Therapy CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Table 11. Global Cell Therapy CDMO Services Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cell Therapy CDMO Services Revenue Market Share by Player (2021-2026)
Table 13. Cell Therapy CDMO Services Key Players Head office and Products Offered
Table 14. Cell Therapy CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell Therapy CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cell Therapy CDMO Services Market Size Market Share by Region (2021-2026)
Table 19. Global Cell Therapy CDMO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cell Therapy CDMO Services Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cell Therapy CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cell Therapy CDMO Services Market Size Market Share by Country (2021-2026)
Table 23. Americas Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Table 25. Americas Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Table 27. APAC Cell Therapy CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cell Therapy CDMO Services Market Size Market Share by Region (2021-2026)
Table 29. APAC Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cell Therapy CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cell Therapy CDMO Services Market Size Market Share by Country (2021-2026)
Table 33. Europe Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cell Therapy CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cell Therapy CDMO Services
Table 39. Key Market Challenges & Risks of Cell Therapy CDMO Services
Table 40. Key Industry Trends of Cell Therapy CDMO Services
Table 41. Global Cell Therapy CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cell Therapy CDMO Services Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cell Therapy CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cell Therapy CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Charles River Laboratories Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 46. Charles River Laboratories Cell Therapy CDMO Services Product Offered
Table 47. Charles River Laboratories Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Charles River Laboratories Main Business
Table 49. Charles River Laboratories Latest Developments
Table 50. AGC Biologics Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 51. AGC Biologics Cell Therapy CDMO Services Product Offered
Table 52. AGC Biologics Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. AGC Biologics Main Business
Table 54. AGC Biologics Latest Developments
Table 55. FUJIFILM Cellular Dynamics Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 56. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Offered
Table 57. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. FUJIFILM Cellular Dynamics Main Business
Table 59. FUJIFILM Cellular Dynamics Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Cell Therapy CDMO Services Product Offered
Table 62. Thermo Fisher Scientific Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. Wuxi AppTec Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 66. Wuxi AppTec Cell Therapy CDMO Services Product Offered
Table 67. Wuxi AppTec Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Wuxi AppTec Main Business
Table 69. Wuxi AppTec Latest Developments
Table 70. Lonza Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 71. Lonza Cell Therapy CDMO Services Product Offered
Table 72. Lonza Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Lonza Main Business
Table 74. Lonza Latest Developments
Table 75. KBI Biopharma Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 76. KBI Biopharma Cell Therapy CDMO Services Product Offered
Table 77. KBI Biopharma Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. KBI Biopharma Main Business
Table 79. KBI Biopharma Latest Developments
Table 80. RoslinCT Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 81. RoslinCT Cell Therapy CDMO Services Product Offered
Table 82. RoslinCT Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. RoslinCT Main Business
Table 84. RoslinCT Latest Developments
Table 85. Cell and Gene Therapy Catapult Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 86. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Offered
Table 87. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Cell and Gene Therapy Catapult Main Business
Table 89. Cell and Gene Therapy Catapult Latest Developments
Table 90. Cell Therapies Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 91. Cell Therapies Cell Therapy CDMO Services Product Offered
Table 92. Cell Therapies Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Cell Therapies Main Business
Table 94. Cell Therapies Latest Developments
Table 95. Minaris Regenerative Medicine Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 96. Minaris Regenerative Medicine Cell Therapy CDMO Services Product Offered
Table 97. Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Minaris Regenerative Medicine Main Business
Table 99. Minaris Regenerative Medicine Latest Developments
Table 100. MEDINET Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 101. MEDINET Cell Therapy CDMO Services Product Offered
Table 102. MEDINET Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. MEDINET Main Business
Table 104. MEDINET Latest Developments
Table 105. Catalent Biologics Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 106. Catalent Biologics Cell Therapy CDMO Services Product Offered
Table 107. Catalent Biologics Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Catalent Biologics Main Business
Table 109. Catalent Biologics Latest Developments
Table 110. Oxford BioMedica Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 111. Oxford BioMedica Cell Therapy CDMO Services Product Offered
Table 112. Oxford BioMedica Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Oxford BioMedica Main Business
Table 114. Oxford BioMedica Latest Developments
Table 115. GenScript Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 116. GenScript Cell Therapy CDMO Services Product Offered
Table 117. GenScript Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. GenScript Main Business
Table 119. GenScript Latest Developments
Table 120. Cell-Easy Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 121. Cell-Easy Cell Therapy CDMO Services Product Offered
Table 122. Cell-Easy Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Cell-Easy Main Business
Table 124. Cell-Easy Latest Developments
Table 125. SK pharmteco Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 126. SK pharmteco Cell Therapy CDMO Services Product Offered
Table 127. SK pharmteco Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. SK pharmteco Main Business
Table 129. SK pharmteco Latest Developments
Table 1. Cell Therapy CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell Therapy CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Preclinical Stage
Table 4. Major Players of Clinical Commercialization Stage
Table 5. Cell Therapy CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Table 8. Cell Therapy CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Table 11. Global Cell Therapy CDMO Services Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cell Therapy CDMO Services Revenue Market Share by Player (2021-2026)
Table 13. Cell Therapy CDMO Services Key Players Head office and Products Offered
Table 14. Cell Therapy CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell Therapy CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cell Therapy CDMO Services Market Size Market Share by Region (2021-2026)
Table 19. Global Cell Therapy CDMO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cell Therapy CDMO Services Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cell Therapy CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cell Therapy CDMO Services Market Size Market Share by Country (2021-2026)
Table 23. Americas Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Table 25. Americas Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Table 27. APAC Cell Therapy CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cell Therapy CDMO Services Market Size Market Share by Region (2021-2026)
Table 29. APAC Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cell Therapy CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cell Therapy CDMO Services Market Size Market Share by Country (2021-2026)
Table 33. Europe Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cell Therapy CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell Therapy CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell Therapy CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cell Therapy CDMO Services
Table 39. Key Market Challenges & Risks of Cell Therapy CDMO Services
Table 40. Key Industry Trends of Cell Therapy CDMO Services
Table 41. Global Cell Therapy CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cell Therapy CDMO Services Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cell Therapy CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cell Therapy CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Charles River Laboratories Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 46. Charles River Laboratories Cell Therapy CDMO Services Product Offered
Table 47. Charles River Laboratories Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Charles River Laboratories Main Business
Table 49. Charles River Laboratories Latest Developments
Table 50. AGC Biologics Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 51. AGC Biologics Cell Therapy CDMO Services Product Offered
Table 52. AGC Biologics Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. AGC Biologics Main Business
Table 54. AGC Biologics Latest Developments
Table 55. FUJIFILM Cellular Dynamics Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 56. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Offered
Table 57. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. FUJIFILM Cellular Dynamics Main Business
Table 59. FUJIFILM Cellular Dynamics Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Cell Therapy CDMO Services Product Offered
Table 62. Thermo Fisher Scientific Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. Wuxi AppTec Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 66. Wuxi AppTec Cell Therapy CDMO Services Product Offered
Table 67. Wuxi AppTec Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Wuxi AppTec Main Business
Table 69. Wuxi AppTec Latest Developments
Table 70. Lonza Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 71. Lonza Cell Therapy CDMO Services Product Offered
Table 72. Lonza Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Lonza Main Business
Table 74. Lonza Latest Developments
Table 75. KBI Biopharma Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 76. KBI Biopharma Cell Therapy CDMO Services Product Offered
Table 77. KBI Biopharma Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. KBI Biopharma Main Business
Table 79. KBI Biopharma Latest Developments
Table 80. RoslinCT Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 81. RoslinCT Cell Therapy CDMO Services Product Offered
Table 82. RoslinCT Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. RoslinCT Main Business
Table 84. RoslinCT Latest Developments
Table 85. Cell and Gene Therapy Catapult Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 86. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Offered
Table 87. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Cell and Gene Therapy Catapult Main Business
Table 89. Cell and Gene Therapy Catapult Latest Developments
Table 90. Cell Therapies Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 91. Cell Therapies Cell Therapy CDMO Services Product Offered
Table 92. Cell Therapies Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Cell Therapies Main Business
Table 94. Cell Therapies Latest Developments
Table 95. Minaris Regenerative Medicine Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 96. Minaris Regenerative Medicine Cell Therapy CDMO Services Product Offered
Table 97. Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Minaris Regenerative Medicine Main Business
Table 99. Minaris Regenerative Medicine Latest Developments
Table 100. MEDINET Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 101. MEDINET Cell Therapy CDMO Services Product Offered
Table 102. MEDINET Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. MEDINET Main Business
Table 104. MEDINET Latest Developments
Table 105. Catalent Biologics Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 106. Catalent Biologics Cell Therapy CDMO Services Product Offered
Table 107. Catalent Biologics Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Catalent Biologics Main Business
Table 109. Catalent Biologics Latest Developments
Table 110. Oxford BioMedica Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 111. Oxford BioMedica Cell Therapy CDMO Services Product Offered
Table 112. Oxford BioMedica Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Oxford BioMedica Main Business
Table 114. Oxford BioMedica Latest Developments
Table 115. GenScript Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 116. GenScript Cell Therapy CDMO Services Product Offered
Table 117. GenScript Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. GenScript Main Business
Table 119. GenScript Latest Developments
Table 120. Cell-Easy Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 121. Cell-Easy Cell Therapy CDMO Services Product Offered
Table 122. Cell-Easy Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Cell-Easy Main Business
Table 124. Cell-Easy Latest Developments
Table 125. SK pharmteco Details, Company Type, Cell Therapy CDMO Services Area Served and Its Competitors
Table 126. SK pharmteco Cell Therapy CDMO Services Product Offered
Table 127. SK pharmteco Cell Therapy CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. SK pharmteco Main Business
Table 129. SK pharmteco Latest Developments
LIST OF FIGURES
Figure 1. Cell Therapy CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Therapy CDMO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell Therapy CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell Therapy CDMO Services Sales Market Share by Country/Region (2025)
Figure 8. Cell Therapy CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell Therapy CDMO Services Market Size Market Share by Type in 2025
Figure 10. Cell Therapy CDMO Services in Pharmaceutical Company
Figure 11. Global Cell Therapy CDMO Services Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 12. Cell Therapy CDMO Services in Research Institute
Figure 13. Global Cell Therapy CDMO Services Market: Research Institute (2021-2026) & ($ millions)
Figure 14. Global Cell Therapy CDMO Services Market Size Market Share by Application in 2025
Figure 15. Global Cell Therapy CDMO Services Revenue Market Share by Player in 2025
Figure 16. Global Cell Therapy CDMO Services Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cell Therapy CDMO Services Market Size 2021-2026 ($ millions)
Figure 18. APAC Cell Therapy CDMO Services Market Size 2021-2026 ($ millions)
Figure 19. Europe Cell Therapy CDMO Services Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cell Therapy CDMO Services Market Size 2021-2026 ($ millions)
Figure 21. Americas Cell Therapy CDMO Services Value Market Share by Country in 2025
Figure 22. United States Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cell Therapy CDMO Services Market Size Market Share by Region in 2025
Figure 27. APAC Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Figure 29. China Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cell Therapy CDMO Services Market Size Market Share by Country in 2025
Figure 36. Europe Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cell Therapy CDMO Services Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 52. APAC Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 53. Europe Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 55. United States Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 56. Canada Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 59. China Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 60. Japan Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 61. Korea Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 63. India Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 64. Australia Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 65. Germany Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 66. France Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 67. UK Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 68. Italy Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 69. Russia Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 72. Israel Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 74. Global Cell Therapy CDMO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cell Therapy CDMO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 1. Cell Therapy CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Therapy CDMO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell Therapy CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell Therapy CDMO Services Sales Market Share by Country/Region (2025)
Figure 8. Cell Therapy CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell Therapy CDMO Services Market Size Market Share by Type in 2025
Figure 10. Cell Therapy CDMO Services in Pharmaceutical Company
Figure 11. Global Cell Therapy CDMO Services Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 12. Cell Therapy CDMO Services in Research Institute
Figure 13. Global Cell Therapy CDMO Services Market: Research Institute (2021-2026) & ($ millions)
Figure 14. Global Cell Therapy CDMO Services Market Size Market Share by Application in 2025
Figure 15. Global Cell Therapy CDMO Services Revenue Market Share by Player in 2025
Figure 16. Global Cell Therapy CDMO Services Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cell Therapy CDMO Services Market Size 2021-2026 ($ millions)
Figure 18. APAC Cell Therapy CDMO Services Market Size 2021-2026 ($ millions)
Figure 19. Europe Cell Therapy CDMO Services Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cell Therapy CDMO Services Market Size 2021-2026 ($ millions)
Figure 21. Americas Cell Therapy CDMO Services Value Market Share by Country in 2025
Figure 22. United States Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cell Therapy CDMO Services Market Size Market Share by Region in 2025
Figure 27. APAC Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Figure 29. China Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cell Therapy CDMO Services Market Size Market Share by Country in 2025
Figure 36. Europe Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cell Therapy CDMO Services Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cell Therapy CDMO Services Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cell Therapy CDMO Services Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cell Therapy CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 52. APAC Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 53. Europe Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 55. United States Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 56. Canada Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 59. China Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 60. Japan Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 61. Korea Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 63. India Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 64. Australia Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 65. Germany Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 66. France Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 67. UK Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 68. Italy Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 69. Russia Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 72. Israel Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
Figure 74. Global Cell Therapy CDMO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cell Therapy CDMO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cell Therapy CDMO Services Market Size 2027-2032 ($ millions)
